Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The humoral response and antibodies against SARS-CoV-2 infection
Hai Qi, Bo Liu, Xinquan Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 7, pp. 1008-1020
Open Access | Times Cited: 144

Showing 1-25 of 144 citing articles:

Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses
Yanjia Chen, Xiaoyu Zhao, Hao Zhou, et al.
Nature reviews. Immunology (2022) Vol. 23, Iss. 3, pp. 189-199
Open Access | Times Cited: 272
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant in mice
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
Nature Medicine (2022) Vol. 29, Iss. 1, pp. 247-257
Open Access | Times Cited: 150
Risk Factors of Severe COVID-19: A Review of Host, Viral and Environmental Factors
Levente Zsichla, Viktor Müller
Viruses (2023) Vol. 15, Iss. 1, pp. 175-175
Open Access | Times Cited: 66
Repeated vaccination of inactivated SARS-CoV-2 vaccine dampens neutralizing antibodies against Omicron variants in breakthrough infection
Bo Gao, Liheng He, Yu-Jie Bao, et al.
Cell Research (2023) Vol. 33, Iss. 3, pp. 258-261
Open Access | Times Cited: 51
Characterizing Long COVID in Children and Adolescents
Rachel S. Gross, Tanayott Thaweethai, Lawrence C. Kleinman, et al.
JAMA (2024) Vol. 332, Iss. 14, pp. 1174-1174
Closed Access | Times Cited: 17
Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Human memory B cells show plasticity and adopt multiple fates upon recall response to SARS-CoV-2
Yves Zurbuchen, Jan Michler, Patrick Taeschler, et al.
Nature Immunology (2023) Vol. 24, Iss. 6, pp. 955-965
Open Access | Times Cited: 26
Safety and immunogenicity of a protein subunit COVID-19 vaccine (ZF2001) in healthy children and adolescents aged 3–17 years in China: a randomised, double-blind, placebo-controlled, phase 1 trial and an open-label, non-randomised, non-inferiority, phase 2 trial
Lidong Gao, Yan Li, Peng He, et al.
The Lancet Child & Adolescent Health (2023) Vol. 7, Iss. 4, pp. 269-279
Open Access | Times Cited: 16
Structural delineation and computational design of SARS-CoV-2-neutralizing antibodies against Omicron subvariants
Saya Moriyama, Yuki Anraku, Shunta Taminishi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 16
SARS-CoV-2 activates the TLR4/MyD88 pathway in human macrophages: A possible correlation with strong pro-inflammatory responses in severe COVID-19
Sabina Sahanic, Richard Hilbe, Christina Dünser, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21893-e21893
Open Access | Times Cited: 15
Testing for SARS-CoV-2: lessons learned and current use cases
Elitza S. Theel, James E. Kirby, Nira R. Pollock
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 5
Nanoparticle Vaccine Triggers Interferon-Gamma Production and Confers Protective Immunity against Porcine Reproductive and Respiratory Syndrome Virus
Yangyang Sun, Yanni Gao, Tongjian Su, et al.
ACS Nano (2025)
Closed Access
Structural insights into hybridoma-derived neutralizing monoclonal antibodies against Omicron BA.5 and XBB.1.16 variants of SARS-CoV-2
Hengrui Hu, Chengcheng Leng, Yanni Shu, et al.
Journal of Virology (2025)
Open Access
Antibody responses in Omicron BF.7-infected patients vaccinated with inactivated SARS-CoV-2
Yabo Zhao, Weili Li, Liming Xu, et al.
Virology (2025) Vol. 603, pp. 110404-110404
Closed Access
Estimating SARS‐CoV‐2 Omicron XBB.1.5 Spike‐Directed Functional Antibody Levels From an Anti‐Receptor Binding Domain Wuhan‐Hu‐1‐Based Commercial Immunoassay Results
Ángela Sánchez‐Simarro, Enric Cuevas‐Ferrando, Daniel Fernández‐Soto, et al.
Journal of Medical Virology (2025) Vol. 97, Iss. 1
Open Access
Multi-molecular phenotyping in a self-sampling population
Leo Dahl, Annika Bendes, María Bueno Álvez, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility
Mengxin Xu, Zhaoyong Zhang, Yuzhu Sun, et al.
Antiviral Research (2025) Vol. 235, pp. 106082-106082
Closed Access
Investigation of Immunoreactivity Profiles and Epitope Landscape in Divergent COVID-19 Trajectories and SARS-CoV-2 Variants
Surbhi Bihani, Arka Ray, Dhanush Borishetty, et al.
Journal of Proteome Research (2025)
Closed Access
Mechanistic models of humoral kinetics following COVID-19 vaccination
Daniel Stocks, Amy Thomas, Adam Finn, et al.
Journal of The Royal Society Interface (2025) Vol. 22, Iss. 222
Open Access
COVID-19 clinical presentation, management, and epidemiology: a concise compendium
David P. Maison, Hawi Tasissa, Amelia N. Deitchman, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Dynamics of spike-specific neutralizing antibodies across five-year emerging SARS-CoV-2 variants of concern reveal conserved epitopes that protect against severe COVID-19
Latifa Zayou, Swayam Prakash, Hawa Vahed, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
NIEAs elicited by wild-type SARS-CoV-2 primary infection fail to enhance the infectivity of Omicron variants
Qi Gui, Haiyan Wang, Congcong Liu, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Longitudinal humoral immunity against SARS-CoV-2 Spike following infection in individuals from Cameroon
Mehdi Benlarbi, Dell-Dylan Kenfack, Katrina Dionne, et al.
Virology (2025) Vol. 605, pp. 110467-110467
Closed Access
Severe Acute Respiratory Syndrome Coronavirus 2 Immunology and Coronavirus Disease 2019 Clinical Outcomes
Aljawharah Alrubayyi, Hsinyen Huang, Gaurav D. Gaiha
Infectious Disease Clinics of North America (2025)
Closed Access
Bivalent SARS-CoV-2 mRNA vaccines increase breadth of neutralization and protect against the BA.5 Omicron variant
Suzanne M. Scheaffer, Diana Lee, Bradley Whitener, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top